|
The board of directors of Ranbaxy Laboratories Ltd has approved listing the cos shares in the United States. The company said that this could be either through the conversion of existing global depository receipts into American depository receipts or through issue of fresh shares.
|
|
|
|
|
| Posted : 9/10/2005 |
|
|
|
|
